23 December 2020
Malaysia’s authorities signed a deal on purchasing 6.4 mln doses of a coronavirus vaccine produced by British-Swedish pharmaceutical company AstraZeneca and also expect Russia’s Sputnik V, Prime Minister Muhyiddin Yassin said in his televised speech on Tuesday (22 December).
The Vaccine Supplies Access Guarantee Special Committee, co-chaired by the Health Minister and the Science, Technology and Innovation Minister, will ensure the vaccines could be acquired fast, he said. The government is also “in the final stage of negotiation with Sinovac, CanSino and Gamaleya [Sputnik V producer] to secure vaccine supply.”
“We will make certain that the acquired vaccines are safe and effective,” he stressed, also announcing plans to be among the first ones to receive the vaccine.
On December 13, the head of government said in late November 3 bln Malaysian ringgits ($700 mln) had been allocated to purchase the vaccine. Last month, an agreement was reached with Pfizer, which is due to supply 12.8 mln doses of the vaccine in 2021.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024
Microbial burden assessment of solid pharmaceutical products
22 April 2024
Seasonal variation of microbial contamination in pharmaceutical cleanrooms
22 April 2024